Please use this identifier to cite or link to this item:
|Title:||Kawasaki disease: a comprehensive review||Autores:||Ramphul, K.
González Mejías, Stephanie
|Researchers (UNIBE):||González Mejías, Stephanie||Affiliations:||Facultad de Ciencias de la Salud||Research area:||Ciencias de la Salud||Keywords:||Kawasaki disease; Aspirin; Coronary aneurysm||Issue Date:||2018||Publisher:||Termedia Publishing House||Source:||Archives of Medical Sciences. Atherosclerotic Diseases, 3, e41-e45||Journal:||Archives of Medical Sciences. Atherosclerotic Diseases||Volume:||3||Issue:||e41||Start page:||e45||Abstract:||
Kawasaki disease is an acute systemic vasculitis that was first reported in 1961. Over the last 5 decades multiple papers have been published to further understand this disease. The diagnosis of Kawasaki disease is made based on the clinical findings. Atypical Kawasaki disease includes patients who do not meet all the criteria for diagnosis. The main complication of Kawasaki disease is coronary aneurysm, and the treatment is intravenous immunoglobulin and aspirin. A second dose of immunoglobulin is given if the patient does not improve, and several other treatment options have been proposed over the last few years as second and third line options.
|Appears in Collections:||Publicaciones de la Facultad de Ciencias de la Salud|
Show full item record Recommend this item
Files in This Item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.